Answers are grounded in this paper and cite their sources.
Formulation optimization demonstrates improved ophthalmic chloramphenicol stability and delivery using poloxamer 407 and HPMC, highlighting a strategy to prevent blurry vision.
The primary goal was to enhance the stability and bioavailability of chloramphenicol for ophthalmic use without compromising patient comfort, such as causing blurry vision. This study employed a 2-level full factorial design to optimize the formulation, exploring different concentrations of poloxamer 407 and HPMC to achieve this objective.
No takes yet. Share an insight, caveat, or question.
Kurniawansyah et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: